ADENOVERSE

Welcome to the Brand page for “ADENOVERSE”, which is offered here for Medical services, providing medical therapy treatments for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases; medical research in the field of immunotherapy;scientific and technological services and biological research and development relating thereto, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of immune cells; scientific and technological services and biological research and development, research and development related to treatment of complex diseases;.

Its status is currently believed to be active. Its class is unavailable. “ADENOVERSE” is believed to be currently owned by “PRECIGEN, INC.”